title: LAV/HTLV-III seroconversion and disease in hemophiliacs treated in France.
authors.forename: D
authors.initials: D
authors.lastname: Mathez
authors.forename: J
authors.initials: J
authors.lastname: Leibovitch
authors.forename: Y
authors.initials: Y
authors.lastname: Sultan
authors.forename: P
authors.initials: P
authors.lastname: Maisonneuve
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000453:epidemiology*; D000914:Antibodies, Viral / Q000032:analysis*; D005169:Factor VIII / Q000009:adverse effects; D005602:France; D015483:HIV Antibodies; D006467:Hemophilia A / Q000276:immunology* / Q000628:therapy; D002836:Hemophilia B / Q000276:immunology / Q000628:therapy; D006801:Humans; D013997:Time Factors
chemical_list: D000914:Antibodies, Viral; D015483:HIV Antibodies; D005169:Factor VIII